Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,000 shares at $130.04 ($1.3M) on 2023-12-22, disclosed to the SEC on 2023-12-27.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-08-15 | $3.5M | — | Filing → |